Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection by Maazi, Hadi et al.
 
Lack of PD-L1 Expression by iNKT Cells Improves the Course of
Influenza A Infection
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Maazi, Hadi, Abinav K. Singh, Anneliese O. Speak, Vincent
Lombardi, Jonathan Lam, Bryant Khoo, Kyung Soo Inn, Arlene H.
Sharpe, Jae U. Jung, and Omid Akbari. 2013. Lack of PD-L1
expression by iNKT cells improves the course of influenza A
infection. PLoS ONE 8(3): e59599.
Published Version doi:10.1371/journal.pone.0059599
Accessed February 19, 2015 12:06:10 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11181187
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAALack of PD-L1 Expression by iNKT Cells Improves the
Course of Influenza A Infection
Hadi Maazi
1., Abinav K. Singh
1., Anneliese O. Speak
1, Vincent Lombardi
1, Jonathan Lam
1, Bryant Khoo
1,
Kyung Soo Inn
1, Arlene H. Sharpe
2, Jae U. Jung
1, Omid Akbari
1*
1Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America,
2Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
There is evidence indicating that invariant Natural Killer T (iNKT) cells play an important role in defense against influenza A
virus (IAV). However, the effect of inhibitory receptor, programmed death-1 (PD-1), and its ligands, programmed death
ligand (PD-L) 1 and 2 on iNKT cells in protection against IAV remains to be elucidated. Here we investigated the effects of
these co-stimulatory molecules on iNKT cells in the response to influenza. We discovered that compare to the wild type, PD-
L1 deficient mice show reduced sensitivity to IAV infection as evident by reduced weight loss, decreased pulmonary
inflammation and cellular infiltration. In contrast, PD-L2 deficient mice showed augmented weight loss, pulmonary
inflammation and cellular infiltration compare to the wild type mice after influenza infection. Adoptive transfer of iNKT cells
from wild type, PD-L1 or PD-L2 deficient mice into iNKT cell deficient mice recapitulated these findings. Interestingly, in our
transfer system PD-L1
2/2-derived iNKT cells produced high levels of interferon-gamma whereas PD-L2
2/2-derived iNKT cells
produced high amounts of interleukin-4 and 13 suggesting a role for these cytokines in sensitivity to influenza. We
identified that PD-L1 negatively regulates the frequency of iNKT cell subsets in the lungs of IAV infected mice. Altogether,
these results demonstrate that lack of PD-L1 expression by iNKT cells reduces the sensitivity to IAV and that the presence of
PD-L2 is important for dampening the deleterious inflammatory responses after IAV infection. Our findings potentially have
clinical implications for developing new therapies for influenza.
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Introduction
Influenza A virus (IAV) infections represent a major public
health threat, particularly in the case of children, the elderly and
those with underlying diseases, all of whom are at an increased risk
for disease complications and death following IAV infection [1,2].
Seasonal outbreaks alone cause an estimated 200,000 hospitaliza-
tions and over 30,000 deaths annually in the United States [3].
Immune system plays an important role in the resolution of IAV
infection. Both mucosal and systemic immunity play important
roles in the elimination of infection with IAV [4,5,6]. Accumu-
lating evidence in the last few years suggests an important role for
conventional CD4
+ and CD8
+ T cells in the control and clearance
of the IAV [7,8,9]. However, in recent years, a relatively new T
cell population, invariant natural killer T (iNKT) cells, have been
reported to act not only as innate lymphocytes but also as
regulators of adaptive immune responses [10,11].
iNKT cells have been suggested to play critical roles in a wide
range of immune responses by acting in a pro-inflammatory or
anti-inflammatory manner [12,13]. They are a specialized subset
of T lymphocytes expressing markers of the NK cell lineage and
an invariant T cell receptor (TCR) [14]. In contrast to
conventional T cells, iNKT cells recognize self and exogenous
lipid antigens presented by the MHC class I-like molecule CD1d
[15,16]. Upon lipid recognition through their TCR, iNKT cells
secrete a range of cytokines with opposing effects on immune
responses, which contribute to the activation of NK, T and B cells,
and dendritic cells (DCs) [17]. This functional property establishes
iNKT cells as innate immune effector cells as well as regulators of
adaptive immune responses. Numerous studies have shown that,
upon activation, iNKT cells either suppress or enhance immune-
mediated responses during inflammation, cancer, autoimmune
diseases and infection [15,18,19,20]. There is evidence indicating
that iNKT cell responses to viral infection require interaction of
iNKT cells with DCs where co-stimulatory interactions may play
an important role in determining the outcome of the response.
The PD-1: PD-1 ligand co-stimulatory interaction is a recently
characterized signaling pathways within the B7: CD28 superfam-
ily. This co-stimulation consists of the PD-1 receptor and its two
ligands PD-L1 (B7-H1) and PD-L2 (B7-DC). PD-L1 is expressed
in a wide variety of tissues and by a number of different cell types
including T cells, NK T cells and DCs [21,22,23,24], and its
expression is up-regulated by IFN- c [25,26]. The expression of
PD-L2 is much more restricted and appears to be limited to
a subset of bone marrow-derived cells, including DCs and
macrophages [23,27]. PD-1 is an inhibitory co-receptor that is
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inhibitory signal upon recognition of either of its ligands.
Cytokines such as IFN-c and IL-4 that are produced after T cell
activation increase the expression of PD-1 ligands at mucosal
surfaces, leading to attenuate the immune response [28]. Although
PD-1 has been well characterized as a negative regulator of
conventional CD4
+ T cells, the role of PD-1 and its interaction
with PD1 ligands in regulating activation and function of iNKT
cells after infection with IAV has not been investigated.
In the present study, we examined the relative contribution of
PD-L1 and PD-L2 to the modulation of immune responses after
IAV infection. We determined that in the absence of PD-L2
animals succumb more rapidly compared to wild type animals
after infection with a lethal dose of IAV virus. This is associated
with an increased cellular infiltration into the lungs and enhanced
pulmonary inflammation. In contrast, in PD-L1 deficient mice the
severity of cellular infiltration and pulmonary inflammation is
reduced. This differential regulation of the response to IAV
infection is associated with alterations to cytokine production by
iNKT cells. These results suggest that under normal circumstances
PD-1/PD-L1 interactions are negative regulators of viral clear-
ance, whereas PD-1/PD-L2 interactions are important for
dampening deleterious inflammation. Therefore, our findings
may have important clinical implications in the sense that
targeting PD-1 co-stimulation in vivo may provide a novel
therapeutic target for controlling and enhancing host immune
responses to IAV allowing an enhanced response with reduced
inflammation.
Materials and Methods
Mice
Female BALB/c ByJ mice were purchased from Jackson
Laboratories. Ja18
2/2 mice (backcrossed to BALB/c) were a gift
from M. Taniguchi/T. Nakayama (Chiba University, Chiba,
Japan) and S. Balk (Brigham and Women’s Hospital, Boston,
Massachusetts) [29]. PD-L1
2/2, PD-L2
2/2 and PD-L1
2/2 PD-
L2
2/2 double knockout mice backcrossed to BALB/cByJ mice for
11 generations were obtained from Arlene Sharpe (Harvard
Medical School, Boston, Massachusetts) [30]. Mice were main-
tained and used according to institutional and National Institutes
of Health guidelines in a pathogen-free facility. The Animal Care
and Use Committee, University of Southern California approved
all animal protocols. A loss of 25% or more of body weight was the
criterion for euthanasia according to our IACUC protocol.
Influenza A infection
Six to eight week-old adult mice were anesthetized with
ketamine (200 mg/kg)/xylazine (20 mg/kg) and inoculated in-
tranasally (i.n.) with IAV (strain PR8, H1N1) in 50 ml saline. The
virus was grown and harvested from 10-day embryonated chicken
eggs as previously described [31]. A dose of 3000 PFU/mouse was
chosen as the lethal dose. Control (mock-infected) mice were
treated with i.n. allantoic fluid (AF) diluted 1:500 in saline.
Flow cytometry analysis
In all experiments, lungs were aseptically removed, minced using
sterilerazorblades,andincubatedin1.6 mg/mlcollagenase(CLS4,
Worthington Biochemicals, Lakewood, NJ) and 30 mg/ml DNAse
(Sigma-Aldrich, St. Louis, MI) at 37uC for 90 min. To achieve
a single-cell suspension, lung fragments were pressed through a 70-
mmporenyloncellstrainerusingtheflatendofasterile3-mlsyringe
plunger. Enzymatic action was terminated by washing cells twice in
complete RPMI (RPMI 1640 with L-glutamine and 10% fetal
bovine serum (FBS)) by centrifugation at 4006g for 5 min at 4uC.
Leukocytes were isolated by centrifugation over a 30–70% Percoll
gradient (GE Healthcare, Piscataway, NJ). Cells were then pre-
incubated for 30 min. with normal rat serum, and washed before
staining. iNKT cells were identified using various antibody
combinations that included PE conjugated CD1d: PBS-57 loaded
tetramer (NIH, NIAID tetramer core facility, Atlanta GA), TCRb-
allophycocyanin (APC) (clone H57-597, eBioscience, San Diego,
CA) and CD4-APC-eFluor750 (clone RM4-5) (eBioscience). Cells
were acquired on the FACSCanto II 8 color flow cytometer (BD
Biosciences, San Jose, CA) and 10,000 events within the iNKT cell
gate were collected. The data were analysed with FlowJo 8.6
software (Tree Star Inc., Ashland, OR).
Purification of iNKT cells and their sub-populations
Single cell suspensions were prepared from spleen in accordance
with standard protocols. Splenocytes were labeled with PE-
conjugated CD1d: PBS-57 loaded tetramer for 20 min at 4uC.
Cells were then washed and magnetically labeled with anti-PE
microbeads (Miltenyi Biotec, Auburn, CA). After washing iNKT
cells were obtained by positive selection using an AutoMACS Pro
(Miltenyi Biotec) using the Posseld program. This program is
designed by the manufacturer for enrichment of rare cells using
two cell enrichment columns. Purity of iNKT cells was .80% as
determined by flow cytometry analysis. For detection of CD4
+ and
DN iNKT cells in lungs CD3-FITC and CD4-APC-eFluor750
(both eBioscience) were used. For in vitro studies, iNKT cells were
negatively selected from splenocytes using a cocktail of PE
conjugated mAbs against B220, CD62L, CD8a and CD11c,
(BD Pharmingen, San Jose, CA) followed by incubation with anti-
PE microbeads. The enriched iNKT cell splenocytes were
confirmed to contain an average of .10% iNKT cells by tetramer
staining and flow cytometry analysis.
Cytokine production by iNKT cells
Invariant NKT cells were positively selected from lungs of wild
type, PD-L1
2/2 or PD-L2
2/2 mice five days post infection as
described above. iNKT subsets were positively selected and
subsequently stained with anti-CD4 antibody and sorted into
CD4
+ and DN subsets by FACS on a BD FACSAria III. Once
positively selected iNKT cells were cultured for 48 h and the cells
harvested for cytokine determination by quantitative reverse
transcription polymerase chain reaction (RT-PCR) as previously
described [32]. Briefly, total RNA was extracted from sorted
subtypes or total iNKT cells using the RNAeasy mini kit (Qiagen,
Valencia, CA) and cDNAs were generated with the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad,
CA) according to the manufacturer’s recommendations. Quanti-
fication of mRNA levels was carried out by quantitative real-time
PCR on a CFX96 thermal cycler (Bio-Rad, Hercules, CA) with
predesigned Taqman gene expression assays and reagents, as per
manufacturer’s instructions.
Activation of iNKT cells by dendritic cells in vitro
Negatively enriched iNKT cells were cultured in round bottom
96 well plates with 1610
3 DCs positively isolated after 3 days from
lungs of IAV infected wild type, PD-L1
2/2 or PD-L2
2/2 mice, as
previously described [13]. CD11c
+ DCs were isolated using
CD11c microbeads (Miltenyi Biotec) according to the manufac-
turer’s instructions. Supernatants were collected after 48 hours
and cytokines levels were determined by ELISA (eBioscience).
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Purified iNKT cells (1610
6) from PD-L1
2/2, PD-L2
2/2 or
wild type mice were adoptively transferred into Ja18
2/2 mice
intravenously into the tail vein. Mice were challenged intranasally
24 hours after adoptive transfer with lethal viral dose of 3000 PFU
in 50 ml saline.
BAL fluid analysis
After 5 days of IAV infection, the lungs from PD-L1
2/2, PD-
L2
2/2 or wild type mice were lavaged twice with 1 ml of PBS with
2% FBS and the fluid pooled as described previously [12]. The
relative number of different types of leukocytes was determined
from slide preparations of bronchoalveolar lavage (BAL) fluid
stained with Hematoxylin and Eosin (H&E).
Lung Histology
Following 5 days post IAV infection, lungs from the sacrificed
mice were perfused with 10% formalin-PBS and removed and
fixed immediately in 10% neutral-buffered formalin (v/v). After
overnight fixation, the lungs were processed for histology. The
lung tissue was embedded in paraffin, 3 mm sections were cut and
stained with H&E according to standard protocols. Sections were
scanned using light microscope for inflammation. Images of these
fields were captured by a Nikon eclipse TE 2000-S microscope
(Nikon, USA) objective lens, total magnification 40X, with an in-
line camera and assembled into multipanel figures using Adobe
Photoshop software (version 7.0). Images were analyzed using the
Leica Application suite (Leica Microsystems, Bannockburn, Ill).
Statistical Analysis
Data were analysed with a one-way ANOVA followed by
a Tukey post-test between groups using PRISM v4 software
(Graph Pad). P values of less than 0.05 were considered statistically
significant with * P,0.05, ** P,0.01 and *** P,0.001. Data
represents mean 6 SEM.
Results
iNKT cells play an important role in the control of
influenza viral infection
Previous studies have suggested an important role for iNKT
cells in the protection against IAV in the C57Bl6/J background
[10,11]. Here we first tested whether iNKT cells are recruited to
the lungs after IAV infection and whether these cells play
a protective role in mice with BALB/c background. To this end,
we first evaluated the frequency and the absolute number of iNK
T cells in the lungs of BALB/c mice at day 1, 3 and 7 after
infection. As shown in figure 1A and 1B, at day 3 after IAV
infection there is a significantly higher number of iNKT cells in the
lungs of infected mice compare to day 1, suggesting that IAV
infection leads to recruitment of these cells to the lungs. At day 7
after infection, there is even higher frequency and number of
iNKT cells in the lung compare to day 1 and 3.
We next addressed the role of iNKT cells in reducing the
sensitivity toIAVbyinfectingwildtypeBALB/candJa18
2/2mice
that lack iNKT cells and evaluated the loss of body weight as an
index for influenza progression. As shown in figure 1C, we found
that although initially both strains had the same body weight, after
the second day post infection Ja18
2/2 mice display severer weight
loss compare to wild type BALB/c mice (P,0.05). These data
suggest that iNKTcells playarole inreducing thesensitivity toIAV
infection also in BALB/c background and that this role of iNKT
cells is not strain dependent.
PD-1 and PD-L1 expression on iNKT cells are modulated
in response to IAV infection
After confirming the role of iNKT cells in reducing the
sensitivity to IAV, we addressed the role of co-stimulatory
molecule PD-1 and its ligands on iNKTcells. It is known that
iNKT cells can express PD-1 and PD-L1 but do not express PD-
L2. [13]. We sought to determine whether the expression of these
molecules is modulated after IAV infection. To reach this aim, the
expression of PD-1, PD-L1 and PD-L2 by iNKT cells subsets was
assessed by flow cytometry 5 days after IAV infection. As shown in
figure 2, expression of PD-1 is increased in CD4
+ iNKT cells in
IAV infected mice compare to mock treated control mice.
Interestingly, double negative iNKT cells of IAV infected mice
show even a greater expression of PD-1 compare to mock treated
mice. Similarly, the level of PD-L1 expression by CD4
+ and by
double negative iNKT cells is higher in IAV infected compare to
control mice. As expected, neither CD4
+ nor double negative
iNKT cells express PD-L2 in IAV infected or control mice. These
data suggest that the protective role of iNKT cells may be
mediated by co-stimulatory molecule PD-1 and its ligands.
PD-L1 and PD-L2 modulate sensitivity to IAV infection in
opposing directions
Next we examined the contribution of PD-1 ligands to the
sensitivity to IAV infection at the functional level. To this end, we
compared the severity of IAV infection in wild type BALB/c with
mice lacking PD-L1 and those lacking PD-L2. Body weight loss,
the composition of BAL, lung histology and virus titer in the lungs
were assessed as indications of influenza severity. We found that in
the absence of PD-L1, mice show significantly higher body weight
as compared to wild type mice (P,0.05, Fig. 3A). In contrast, mice
lacking PD-L2 show a greater weigh loss than wild type mice
(P,0.05, Fig. 3A) indicating that PD-L1 contributes to sensitivity
to IAV infection.
The increased weight loss of PD-L2
2/2 mice was associated
with a significant increase in the number of macrophages and
lymphocytes in BAL compared to wild type mice (P,0.05 and
P,0.001, Fig. 3B). Histological analysis of lungs revealed that
compare to wild type mice there is an increased number of
inflammatory cells and epithelium thickness in the lungs of PD-
L2
2/2 mice whereas, there is a decreased number of inflamma-
tory cells and epithelium thickness in the lungs of PD-L1
2/2 mice
(P,0.05, Fig. 3C–D). Similarly, the lungs of PD-L1
2/2 mice
contain a significantly lower titer of IAV at day 3 and 7 post
infection compare to wild type mice. IAV titer in lungs of PD-
L2
2/2 mice is significantly higher compare to wild type mice at 3
and 7 days post infection.
Since we observed that PD-L1 and PD-L2 have opposing
effects, we addressed the response to IAV infection in the absence
of both of these co-stimulatory molecules. To this end, we infected
PD-L1
2/2 PD-L2
2/2 double knockout or wild type BALB/c.
Interestingly, we found that the there is no difference in the level of
weight loss between wild type and PD-L1
2/2 PD-L2
2/2 double
knockout mice (figure S1). These data suggest that PD-L1 and PD-
L2 have the capacity to balance/neutralize each others effect and
therefore, the absence of both results in no phenotype in IAV
resistance or sensitivity.
Taken together, these results indicate that PD-L1
2/2 con-
tributes to the sensitivity to infection and its severity, while PD-
L2
2/2 plays a role in recovery and protection against IAV.
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To determine whether the expression of PD-1 ligands on iNKT
cells or development of these cells in the absence of PD-1 ligands
underlies the altered sensitivity to IAV we performed a series of
adoptive transfer experiments. iNKT cells were positively selected
from the spleen of BALB/c, PD-L1
2/2 or PD-L2
2/2 animals and
adoptively transferred into iNKT cell deficient Ja18
2/2 mice. As
expected Ja18
2/2 mice that did not receive any iNKT cells had
a high rate of weight loss that was reduced after the transfer of wild
type iNKT cells (P,0.05, Fig. 4), confirming the essential role of
these cells. In contrast mice that received PD-L2
2/2 iNKT cells
demonstrated no significant difference in weight loss compare to
animals that did not receive iNKT cells (Fig. 4). Whereas, transfer
of PD-L1
2/2 iNKT cells resulted in enhanced protection from
IAV as evident by the reduced weight loss compared to animals
that received BALB/c iNKT cells and PD-L2
2/2 iNKT cells
(P=0.01, Fig. 4). These data clearly demonstrate that expression
of PD-L1 specifically by iNKT cells contributes to influenza
pathogenesis and severity. Moreover, our results suggest that
although iNKT cells do not express PD-L2, their protective role
against IAV requires the presence of this co-stimulatory molecule
during the development of iNKT cells.
Cytokine profile of pulmonary iNKT cells is regulated by
PD-L1 and PD-L2 co-stimulation
Our adoptive transfer studies suggest that even though iNKT
cells do not express PD-L2 they are functionally affected by
development in a PD-L2 deficient environment. It has been
previously reported that iNKT cells from PD-L1 or PD-L2
knockout mice have altered cytokine polarization [13]. Therefore,
we sought to determine how PD-L1 and PD-L2 signaling might
affect the function of iNKT cells in response to IAV infection.
Lung iNKT cells from IAV infected PD-L1
2/2 mice produced
significantly higher levels of IFN-c compared to wild type BALB/c
and PD-L2
2/2 mice (Fig. 5). In contrast, higher levels of IL-4 were
produced from IAV infected PD-L2
2/2 mice lung iNKT cells
compared to PD-L1
2/2 lung iNKT cells (Fig. 5). PD-L1
2/2 lung
iNKT cells also expressed significantly less IL-4 compared to wild
type BALB/c mice after IAV infection (Fig. 5). These experiments
indicate that signaling through PD-L1 and PD-L2 can skew the
cytokines produced by pulmonary iNKT cells in response to IAV
Figure 1. iNKT cells reduce the sensitivity of BALB/c mice to IAV infection. Ja18
2/2 mice and BALB/c mice (n=10) were intranasally infected
with a lethal dose (3000 PFU) of IAV. (A) Increased frequency of iNKT cells after IAV infection. Representative FACS plots of iNKT cell frequencies in the
lung of BALB/c mice stained with CD1d: PBS57 loaded tetramer and TCR-b antibody, gated on viable lymphocytes with percentage of cells in the iNKT
cell gate indicated next to the gate. (B) Total iNKT cell numbers in the lung were determined by flow cytometry at different days post infection (DPI).
Data is presented as mean 6 standard error of the mean (SEM), n=3. * P.0.05 (C) The weight loss of Ja18
2/2 mice and BALB/c mice has been
monitored daily after IAV infection. Ja18
2/2 mice show augmented weight loss compared to wild type mice. Data are representative of three
independent experiments.
doi:10.1371/journal.pone.0059599.g001
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(PD-L2) profile. The inflammatory cytokine, IL-13, was also
significantly higher in PD-L2
2/2 mice compared PD-L1
2/2 mice
(Fig. 5) whereas there was no significant difference in TNF-
a between the groups of mice (Fig. 5).
PD-L1 and PD-L2 expression on dendritic cells regulates
the iNKT cell after influenza infection
As demonstrated above, cytokine production by iNKT cells is
altered by the absence of PD-L1 or PD-L2. As both PD-L1 and
PD-L2 can be expressed by DCs [13,33,34] we sought to
determine the role of DC expression of these co-stimulatory
molecules on cytokine secretion by iNKT cells. DCs were isolated
from the lungs of IAV infected PD-L1
2/2, PD-L2
2/2 and BALB/
c mice and loaded with an iNKT cell stimulating ligand, a-
galactosylceramide, prior to co-culture with BALB/c iNKT cells.
When using PD-L1
2/2 DCs production of IFN-c was increased
compared to BALB/c or PD-L2
2/2 DCs (Fig. 6). In contrast, PD-
L2
2/2 DCs resulted in enhanced production of IL-4 compared to
wild type and PD-L1
2/2 mice (Fig. 6). Therefore, PD-L1 and PD-
L2 can exert effects on the cytokine profile of iNKT cells through
their expression on the DCs that present antigens to and activate
iNKT cells.
Lack of PD-L1 leads to preferential expansion of double
negative iNKT cell in IAV infected mice
Murine iNKT cells may be either CD4
+CD8
2 (CD4
+)o r
CD4
2CD8
2 (DN) and it has been previously demonstrated that
these different iNKT cell populations produce a different profile of
cytokines [35,36]. Therefore, we reasoned that the differences in
the cytokines produced by the pulmonary iNKT cells in PD-L1
2/
2 and PD-L2
2/2 compared to wild type could be due to
differential composition of iNKT cell subpopulations. Hence, we
determined the relative proportions of CD4
+ and DN iNKT cells
in the lung of IAV infected BALB/c, PD-L1
2/2 and PD-L2
2/2 at
various days post infection. At five days post infection the
frequency of DN iNKT was increased in the PD-L1
2/2 animals
compared to BALB/c and PD-L2
2/2 mice (Fig. 7A). By day 10,
the expansion of DN iNKT cells in the lung of PD-L1
2/2 was
even greater and significantly different compared to wild type
BALB/c and PD-L2
2/2 mice (Fig. 7A). Furthermore, in the lung
of PD-L2
2/2 mice the frequency of CD4
+ iNKT cells was
significantly increased compared to wild type BALB/c mice (gray
Figure 2. Differential expansion of iNKT cell subsets to IAV infection. Expression of PD-1, PD-L1 and PD-L2 on iNKT cells isolated from the
lungs of control or 5 day post IAV infection in BALB/c mice. Dot plots are gated on iNKT cells that were identified as CD1d: PBS57 loaded tetramer
+
TCR-b
intermediate and show CD4 expression on the iNKT cells (Dot plots are representative of 5).
doi:10.1371/journal.pone.0059599.g002
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study that demonstrated the protective role of DN iNKT cells
during the resolution of IAV infection [35]. We reasoned that the
protective role of DN iNKT cells was associated with enhanced
IFN-c secretion. Therefore, we analyzed IFN-c gene expression of
iNKT cell subsets following IAV infection. As shown in figure 7B
Figure 3. PD-L1 and PD-L2 affect the sensitivity and the degree of lung inflammation after infection with IAV. PD-L2
2/2, PD-L1
2/2 and
BALB/c (n=10) mice received a lethal dose of IAV (3000 PFU) intranasally. (A) Weight loss has been monitored by measuring body weight daily post
infection (DPI) (B) BAL was performed in mice (n=5) five days post IAV infection and analyzed for differential cellular infiltration. Bar graph shows
total cell number (Total) and absolute number of eosinophils (EOS), monocytes/macrophages (MAC), lymphocytes (LYM) and neutrophils (PMN). ND:
not detectable. (C) Representative image of lung sections taken 5 days post infection with 3000 PFU IAV stained with H&E (original magnification
640, insert magnification 6100, scale bar 50 mm) from BALB/c, PD-L1
2/2 and PD-L2
2/2 mice. (D) Quantification of lung sections as shown by
measurement of thickness of epithelium, left panel and number of inflammatory cells per 250 mm
2, right panel. (E) Virus titration in the lungs shown
as plaque forming units (PFU) per gram of lung tissue. Data are presented as mean 6 SEM, * P.0.05, ** P.0.01 and *** P.0.001 as calculated by
a one-way ANOVA with Tukey post hoc test and is representative of four independent experiments.
doi:10.1371/journal.pone.0059599.g003
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Figure 4. Lack of PD-L1 expression on iNKT cells reduces
sensitivity to IAV infection. iNKT cells (1610
6) were positively
isolated from spleen of BALB/c, PD-L1
2/2 and PD-L2
2/2 mice and
adoptively transferred into iNKT cell deficient Ja18
2/2 mice. After
24 hours Ja18
2/2 mice received 3000 PFU influenza A intranasally.
Weight loss was monitored at different time points after the infection
with n=5 per group and is representative of three independent
experiments.
doi:10.1371/journal.pone.0059599.g004
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Figure 5. PD-L1 and PD-L2 affect the cytokines produced by
lung iNKT cells after IAV infection. iNKT cells were positively
selected from influenza A infected lungs on day 5 from PD-L1
2/2, PD-
L2
2/2 and wild type BALB/c mice and different cytokines were analysed
by quantitative RT-PCR normalized to b-actin levels. Data presented as
mean 6 SEM. * P.0.05, ** P.0.01 and *** P.0.001 as calculated by
a one-way ANOVA with Tukey post hoc test and is representative of five
independent experiments with n of 5 per group.
doi:10.1371/journal.pone.0059599.g005
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2/2 mice demon-
strated enhanced IFN- c expression compared to PD-L2
2/2 mice.
The expression of IFN-c by the DN iNKT cell subset from PD-
L1
2/2 mice was significantly higher than wild type BALB/c mice
(Fig. 7B) with BALB/c CD4
+ iNKT cells expressing significantly
more IFN-c compared to CD4
+ iNKT cells from PD-L2
2/2 mice
(Fig. 7B). In contrast, IL-4 was increased in both iNKT cell subsets
from PD-L2
2/2 compared to PD-L1
2/2 mice (Fig. 7B). These
findings indicate that the role of iNKT cells in reducing the
severity of IAV in absence of PD-L1 co-stimulation is associated
with the increased DN iNKT cell frequency and enhanced IFN-c
production whereas in the absence of PD-L2 CD4
+ iNKT cells are
increased resulting in the production of more IL-4.
Discussion
Our findings suggest an important role for the PD-1 ligands,
PD-L1 and PD-L2 in regulating the immune response to infection
with IAV. In the absence of PD-L1 mice are less sensitive to IAV
infection as evident by reduced excessive cellular infiltration and
inflammation and weight loss. In contrast, in the absence of PD-L2
pulmonary inflammation and cellular infiltration is increased and
results in a more rapid weight loss. This altered response is
associated with the production of different cytokines by iNKT
cells. Adoptive transfer of iNKT cells from PD-L1 or PD-L2
deficient mice to animals lacking iNKT cells recapitulated the
findings from the whole animal. Interestingly, we found that PD-
L1 and PD-L2 have possibly balancing/neutralizing effects on
each other as PD-L1
2/2 PD-L2
2/2 double knockout mice show
a similar sensitivity to IAV infection as do wild type mice. We also
identified a role for PD-1/PD-L interactions in controlling the
expansion of iNKT cell subsets. In the absence of PD-L1 DN
iNKT cells were increased whereas the opposite occurred in mice
lacking PD-L2 with an increase in CD4
+ iNKT cells. We have also
demonstrated an important role for expression of PD-1 ligands on
DCs in the control of cytokine production by iNKT cells.
Altogether these results indicate that PD-1/PD-L1 interactions
are vital modulators of the immune response and represent novel
targets for therapeutic modification in vivo.
The role of iNKT cells in the control of viral infections is well
characterized. In terms of viral immunity, iNKT cells are involved
in immune surveillance and/or clearance of hepatitis B and C
virus [37,38], respiratory syncytial virus [39], herpes simplex virus
1 and 2 [40,41], and HIV [42]. Several reports have indicated that
iNKT cells are important in IAV clearance. In both murine
infection models and human patients it has been demonstrated
that iNKT cells are required for the generation of adaptive
immune responses by reducing the suppressive effects of myeloid
derived suppressor cells, which expand after infection [10].
Furthermore, activation of iNKT cells with a potent agonist, a-
galactosylceramide, improves the disease course in part through
enhancing innate immune responses [43]. iNKT cells have also
been demonstrated to play an important role in the generation of
influenza specific CD8
+ T cell responses [11]. With all these
findings it is not surprising that iNKT cell deficient Ja18
2/2 mice
are more sensitive to IAV, exhibit a higher rate of weight loss and
increased severity of disease. This influence of iNKT cells on
multiple aspects during the course of IAV infection and clearance
are likely associated with the ability of iNKT cells to produce both
Th1 and Th2 cytokines very rapidly after activation [44].
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Figure 6. PD-L1 and PD-L2 expression on dendritic cells
regulates the iNKT cell cytokine secretions after IAV infection.
Pulmonary DCs (10
3) were isolated from lungs of influenza A infected
PD-L1
2/2, PD-L2
2/2 and wild type BALB/c mice and loaded with 1 mg
of a-galactosylceramide for 3 hours and then cultured with negatively
enriched iNKT cells (1610
4) from the spleen of naı ¨ve wild type mice.
Supernatants were collected after 48 h and IL-4 and IFN- c levels were
measured by ELISA. Data presented as mean 6 SEM. *** P.0.001 as
calculated by a one-way ANOVA with Tukey post hoc test and is
representative of four independent experiments with n of 5 per group.
doi:10.1371/journal.pone.0059599.g006
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Figure 7. iNKT cell subpopulations are modulated in PD-L1
2/2
and PD-L2
2/2 animals after IAV infection. (a) Wild type BALB/c,
PD-L1
2/2 and PD-L2
2/2 mice (n=3) were infected with IAV intranasally.
Lungs were collected at day 1, 5 and 10 post infection and the
frequency of CD4
+ and DN iNKT cells determined by flow cytometry and
compared (DN: black asterisk, CD4
+: gray asterisk). (b) CD4
+ and DN
iNKT cells subsets were sorted from IAV infected lungs on day 5 from
PD-L1
2/2, PD-L2
2/2 and wild type mice BALB/c and IL-4 and IFN- c
were analysed by quantitative RT-PCR normalized to b-actin levels
(n=8). Data presented as mean 6 SEM. * P.0.05, ** P.0.01 and ***
P.0.001 as calculated by a one-way ANOVA with Tukey post hoc test
and is representative of five independent experiments.
doi:10.1371/journal.pone.0059599.g007
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based on their expression of CD4 or not (CD4
+ or DN), are
enriched in the production of certain cytokines [36,45]. Therefore,
it is interesting that after infection with IAV the relative
proportions of iNKT cell subsets in the lungs are altered in the
absence of PD-L1 or PD-L2.
In PD-L1
2/2 mice the frequency of DN iNKT cells, that are
the major producers of IFN-c, is increased. In contrast, in PD-
L2
2/2 mice the proportion of CD4
+ iNKT cells is increased
resulting in the enhanced production of IL-4. Thus, not only does
signaling through the PD-1/PD-L pathway influence the cytokines
production by the iNKT cells but also controls the proportions of
the iNKT cell subsets. The underlying mechanism for this finding
is not clear as yet but may have important implications in attempts
to polarize immune responses in a Th1 or Th2 biased manner. In
addition to iNKT cells, previous reports suggest that T cells, in
particular CD8
+ T cells, play a major role in producing IFN-c that
assists in the clearance of IAV [46,47]. However, recent studies
provide evidence that iNKT cells are important in the generation
of influenza specific CD8
+ T cells responses [11]. Here, we found
that iNKT cells from PD-L1
2/2 mice showed increased IFN-c
production after IAV infection. There is evidence indicating that
IFN-c possesses different opposing functions including pro in-
flammatory Th1 responses and immuneregulatory function
depending on the cytokine milieu and the state of immune
responses [48,49,50]. We also found that pulmonary iNKT cells
from PD-L2
2/2 mice produce more IL-4 and IL-13 after
influenza infection. Although not directly tested at the functional
level, our findings suggest that the altered cytokine profile of iNKT
cells in the absence of PD-L1 or PD-L2 may underlie the observed
difference in IAV sensitivity. During pulmonary inflammation
Th2 cells produce IL-4 and IL-13 [24], which interact with mast
cells or eosinophils to mediate the inflammatory responses. Earlier,
Moran and coworkers reported that treatment of mice with IL-4
resulted in a significant delay in viral clearance [51]. A recent
report suggested that pulmonary IL-13 is responsible for the viral
induced lung inflammation and airway hyperreactivity [52]. Acute
viral infection leads to the production of IL-13 which has been
shown to be responsible for many characteristics of asthma [52].
In our experiments we show that lack of PD-L2 is associated with
increased production of IL-13 by iNKT cells which contributes to
the augmented pathogenesis of IAV infection in these mice.
However, on the other side, it is well established that Type I
interferons are key cytokines produced by IAV-infected epithelial
cells and monocytes and play an important role in clearance of
virus [53,54,55].
The role of the molecules PD-L1 and PD-L2 in the activation
and modulation of iNKT cells in influenza pathogenesis has not
previously been investigated. The PD-1: PD-L pathway is best
known for its ability to negatively regulate immune responses
[33,56]. Most of the evidence for this role comes from models of
tolerance, cancer or chronic infections [30,57,58,59,60]. In the
present study, we observed that PD-L1 expression modulates the
cytokine profile of iNKT cells and consequently regulates the
inflammatory phase after influenza infection. Nevertheless, our
findings regarding the role of PD-1 ligands is focused on the acute
phase of the influenza and the impact of these ligands on the
pathogenesis of influenza during the late phase remains to be
elucidated.
The PD-1 ligands exhibit distinct patterns of expression.
Previous studies have shown that PD-L1 is expressed more
broadly than PD-L2. PD-L1 is expressed on various hematopoietic
and non-hematopoietic cells [21,22,33], whereas, expression of
PD-L2 is predominantly on dendritic cells and macrophages [61].
It has been reported that PD-1 and PD-L1 are expressed in the
lower airways of patients with IAV infection [62]. Interestingly, we
found that IAV infection significantly, increases the expression of
PD-1 and PD-L1 by DN respiratory iNKT cells. However PD-L2
expression by iNKT cells was minimal.
Our in vitro experiments would suggest that even though PD-
L2 is not expressed on iNKT cells, development of iNKT cells in
a PD-L2 deficient environment primes them towards exhibiting
a Th2 like cytokine profile. This is demonstrated in the effects of
adoptively transferred PD-L2
2/2-derived iNKT cells on the
severity of IAV infection in iNKT cell deficient mice. To further
characterize what cell type could express PD-L2 and may be
responsible for altering the cytokine production by iNKT cells we
studied DCs. In a co-culture model naı ¨ve wild type iNKT cells
activated by PD-L2
2/2 DCs demonstrated the same bias of
cytokine production towards IL-4 and IL-13. Taken together, our
findings suggest that development of iNKT cells in the absence of
PD-L2 affects their phenotype towards reduced antiviral char-
acteristics, whereas, lack of PD-L1 expression by iNKT cells or
development of these cells in the absence of PD-L1 primes them
towards an enhanced antiviral phenotype.
Resolution of influenza virus requires a potent anti-viral
immune response on the one hand and regulating the amplitude
of the elicited immune response on the other hand. The control of
the balance between viral clearance and inflammation is a delicate
process that is not fully understood to date. Here we have
confirmed the important role of iNKT cells in the host immune
response after influenza infection and have extended these findings
to the influence of the PD-1/PD-L pathway on the iNKT cell
response. Our data indicates that lack of PD-L1 improves the
course of influenza disease, whereas the presence of PD-L2
provides signals to control the deleterious inflammation. There-
fore, treatment strategies that target these pathways, including
block PD-L1 or enhancing PD-L2 signaling, represent novel
methods for modulating the host’s response after influenza
infection that allow more rapid viral clearance with minimized
inflammation.
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2/2 PDL2
2/2
double knockout and wild type BALB/c mice were infected with
IAV (3000 PFU). Weight loss is monitored daily. Data presented
as mean 6 SEM.
(EPS)
Author Contributions
Conceived and designed the experiments: OA JJ. Performed the
experiments: AKS HM AOS VL BK KSI. Analyzed the data: HM AKS
AOS JL. Contributed reagents/materials/analysis tools: AHS JJ. Wrote the
paper: HM AKS AOS JL OA.
References
1. Barker WH, Mullooly JP (1980) Impact of epidemic type A influenza in a defined
adult population. Am J Epidemiol 112: 798–811.
2. Barker WH, Mullooly JP (1982) Pneumonia and influenza deaths during
epidemics: implications for prevention. Arch Intern Med 142: 85–89.
Lack of PD-L1 Improves Influenza Infection
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e595993. Thompson WW, Comanor L, Shay DK (2006) Epidemiology of seasonal
influenza: use of surveillance data and statistical models to estimate the burden
of disease. J Infect Dis 194 Suppl 2: S82–91.
4. Clements ML, Betts RF, Tierney EL, Murphy BR (1986) Serum and nasal wash
antibodies associated with resistance to experimental challenge with influenza A
wild-type virus. J Clin Microbiol 24: 157–160.
5. Clements ML, Murphy BR (1986) Development and persistence of local and
systemic antibody responses in adults given live attenuated or inactivated
influenza A virus vaccine. J Clin Microbiol 23: 66–72.
6. Murphy BR, Baron S, Chalhub EG, Uhlendorf CP, Chanock RM (1973)
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in
the nasopharynx by wild-type and a temperature-sensitive recombinant virus.
J Infect Dis 128: 488–493.
7. Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, et al. (2008)
Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza
virus infection in mice after vaccination with a low pathogenic H5N2 strain.
Vaccine 26: 6965–6974.
8. La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of self-
preservation: immunopathology in influenza virus infection. Immunol Cell Biol
85: 85–92.
9. Lawrence CW, Ream RM, Braciale TJ (2005) Frequency, specificity, and sites of
expansion of CD8+ T cells during primary pulmonary influenza virus infection.
J Immunol 174: 5332–5340.
10. De Santo C, Salio M, Masri SH, Lee LY, Dong T, et al. (2008) Invariant NKT
cells reduce the immunosuppressive activity of influenza A virus-induced
myeloid-derived suppressor cells in mice and humans. J Clin Invest 118: 4036–
4048.
11. Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, et al. (2011) Potential role
of invariant NKT cells in the control of pulmonary inflammation and CD8+ T
cell response during acute influenza A virus H3N2 pneumonia. J Immunol 186:
5590–5602.
12. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, et al. (2003) Essential
role of NKT cells producing IL-4 and IL-13 in the development of allergen-
induced airway hyperreactivity. Nat Med 9: 582–588.
13. Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, et al. (2010) PD-L1 and
PD-L2 modulate airway inflammation and iNKT-cell-dependent airway
hyperreactivity in opposing directions. Mucosal Immunol 3: 81–91.
14. Barral DC, Brenner MB (2007) CD1 antigen presentation: how it works. Nat
Rev Immunol 7: 929–941.
15. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev
Immunol 25: 297–336.
16. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via
CD1d-dependent NKT cells. J Clin Invest 114: 1379–1388.
17. Tessmer MS, Fatima A, Paget C, Trottein F, Brossay L (2009) NKT cell
immune responses to viral infection. Expert Opin Ther Targets 13: 153–162.
18. Cerundolo V, Silk JD, Masri SH, Salio M (2009) Harnessing invariant NKT
cells in vaccination strategies. Nat Rev Immunol 9: 28–38.
19. Diana J, Brezar V, Beaudoin L, Dalod M, Mellor A, et al. (2011) Viral infection
prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid
dendritic cell interplay. J Exp Med 208: 729–745.
20. Terabe M, Berzofsky JA (2007) NKT cells in immunoregulation of tumor
immunity: a new immunoregulatory axis. Trends Immunol 28: 491–496.
21. Dong H, Zhu G, Tamada K, Chen L (1999) B7-H1, a third member of the B7
family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med
5: 1365–1369.
22. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, et al. (2000)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family
member leads to negative regulation of lymphocyte activation. J Exp Med 192:
1027–1034.
23. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, et al. (2002) Expression of
programmed death 1 ligands by murine T cells and APC. J Immunol 169: 5538–
5545.
24. Kerzerho J, Maazi H, Speak AO, Szely N, Lombardi V, et al. (2012)
Programmed cell death ligand 2 regulates T(H)9 differentiation and induction of
chronic airway hyperreactivity. J Allergy Clin Immunol.
25. Eppihimer MJ, Gunn J, Freeman GJ, Greenfield EA, Chernova T, et al. (2002)
Expression and regulation of the PD-L1 immunoinhibitory molecule on
microvascular endothelial cells. Microcirculation 9: 133–145.
26. Rodig N, Ryan T, Allen JA, Pang H, Grabie N, et al. (2003) Endothelial
expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and
cytolysis. Eur J Immunol 33: 3117–3126.
27. Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, et al. (2006) PD-
L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous
leishmaniasis. Eur J Immunol 36: 58–64.
28. Maier H, Isogawa M, Freeman GJ, Chisari FV (2007) PD-1: PD-L1 interactions
contribute to the functional suppression of virus-specific CD8+ T lymphocytes in
the liver. J Immunol 178: 2714–2720.
29. Cui J, Shin T, Kawano T, Sato H, Kondo E, et al. (1997) Requirement for
Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623–
1626.
30. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, et al. (2006) Tissue
expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 203: 883–
895.
31. Talon J, Salvatore M, O’Neill RE, Nakaya Y, Zheng H, et al. (2000) Influenza A
and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl
Acad Sci U S A 97: 4309–4314.
32. Lombardi V, Stock P, Singh AK, Kerzerho J, Yang W, et al. (2010) A CD1d-
dependent antagonist inhibits the activation of invariant NKT cells and prevents
development of allergen-induced airway hyperreactivity. J Immunol 184: 2107–
2115.
33. Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, et al. (2004) PD-L1-
deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host
tissues negatively regulates T cells. Proc Natl Acad Sci U S A 101: 10691–10696.
34. Zhang Y, Chung Y, Bishop C, Daugherty B, Chute H, et al. (2006) Regulation
of T cell activation and tolerance by PDL2. Proc Natl Acad Sci U S A 103:
11695–11700.
35. Chang YJ, Kim HY, Albacker LA, Lee HH, Baumgarth N, et al. (2011)
Influenza infection in suckling mice expands an NKT cell subset that protects
against airway hyperreactivity. J Clin Invest 121: 57–69.
36. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, et al. (2008)
Diverse cytokine production by NKT cell subsets and identification of an IL-17-
producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A 105:
11287–11292.
37. Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, et al. (2004) Hepatic
CD1d expression in hepatitis C virus infection and recognition by resident
proinflammatory CD1d-reactive T cells. J Immunol 173: 2159–2166.
38. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV (2000) Natural killer T cell
activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921–930.
39. Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS (2002) NK T cells
contribute to expansion of CD8(+) T cells and amplification of antiviral immune
responses to respiratory syncytial virus. J Virol 76: 4294–4303.
40. Ashkar AA, Rosenthal KL (2003) Interleukin-15 and natural killer and NKT
cells play a critical role in innate protection against genital herpes simplex virus
type 2 infection. J Virol 77: 10168–10171.
41. Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG (2003) Impaired
clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT
cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol 170:
1430–1434.
42. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, et al. (2002) CD1d-
restricted human natural killer T cells are highly susceptible to human
immunodeficiency virus 1 infection. J Exp Med 195: 869–879.
43. Ho LP, Denney L, Luhn K, Teoh D, Clelland C, et al. (2008) Activation of
invariant NKT cells enhances the innate immune response and improves the
disease course in influenza A virus infection. Eur J Immunol 38: 1913–1922.
44. Van Dommelen SL, Degli-Esposti MA (2004) NKT cells and viral immunity.
Immunol Cell Biol 82: 332–341.
45. Liu TY, Uemura Y, Suzuki M, Narita Y, Hirata S, et al. (2008) Distinct subsets
of human invariant NKT cells differentially regulate T helper responses via
dendritic cells. Eur J Immunol 38: 1012–1023.
46. Hatta Y, Hershberger K, Shinya K, Proll SC, Dubielzig RR, et al. (2010) Viral
replication rate regulates clinical outcome and CD8 T cell responses during
highly pathogenic H5N1 influenza virus infection in mice. PLoS Pathog 6.
47. Hufford MM, Kim TS, Sun J, Braciale TJ (2011) Antiviral CD8+ T cell effector
activities in situ are regulated by target cell type. J Exp Med 208: 167–180.
48. Kishimoto K, Sandner S, Imitola J, Sho M, Li Y, et al. (2002) Th1 cytokines,
programmed cell death, and alloreactive T cell clone size in transplant tolerance.
J Clin Invest 109: 1471–1479.
49. Wood KJ, Sawitzki B (2006) Interferon gamma: a crucial role in the function of
induced regulatory T cells in vivo. Trends Immunol 27: 183–187.
50. Bocek P Jr., Foucras G, Paul WE (2004) Interferon gamma enhances both in
vitro and in vivo priming of CD4+ T cells for IL-4 production. J Exp Med 199:
1619–1630.
51. Moran TM, Isobe H, Fernandez-Sesma A, Schulman JL (1996) Interleukin-4
causes delayed virus clearance in influenza virus-infected mice. J Virol 70: 5230–
5235.
52. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, et al. (2011)
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity
independently of adaptive immunity. Nat Immunol 12: 631–638.
53. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, et al. (1998) The
role of interferon in influenza virus tissue tropism. J Virol 72: 8550–8558.
54. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, et al. (1997)
Regulation of IFN-alpha/beta, MxA, 29,59-oligoadenylate synthetase, and HLA
gene expression in influenza A-infected human lung epithelial cells. J Immunol
158: 2363–2374.
55. Sareneva T, Matikainen S, Kurimoto M, Julkunen I (1998) Influenza A virus-
induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene
expression in human T cells. J Immunol 160: 6032–6038.
56. Singh AK, Stock P, Akbari O (2011) Role of PD-L1 and PD-L2 in allergic
diseases and asthma. Allergy 66: 155–162.
57. Curran MA, Montalvo W, Yagita H, Allison JP (2010) PD-1 and CTLA-4
combination blockade expands infiltrating T cells and reduces regulatory T and
myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A 107:
4275–4280.
58. Dulgerian LR, Garrido VV, Stempin CC, Cerban FM (2011) Programmed
death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi
survival in macrophages during murine experimental infection. Immunology
133: 29–40.
Lack of PD-L1 Improves Influenza Infection
PLOS ONE | www.plosone.org 9 March 2013 | Volume 8 | Issue 3 | e5959959. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, et al. (2005) A
critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp
Med 202: 231–237.
60. Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, et al. (2011) The
programmed death-1 ligand 1: b7-1 pathway restrains diabetogenic effector T
cells in vivo. J Immunol 187: 1097–1105.
61. Matsumoto K, Inoue H, Nakano T, Tsuda M, Yoshiura Y, et al. (2004) B7-DC
regulates asthmatic response by an IFN-gamma-dependent mechanism.
J Immunol 172: 2530–2541.
62. Erickson JJ, Gilchuk P, Hastings AK, Tollefson SJ, Johnson M, et al. (2012) Viral
acute lower respiratory infections impair CD8+ T cells through PD-1. J Clin
Invest 122: 2967–2982.
Lack of PD-L1 Improves Influenza Infection
PLOS ONE | www.plosone.org 10 March 2013 | Volume 8 | Issue 3 | e59599